The present invention relates to triazine compounds having sodium channel blocking properties, and to use of the compounds for preparation of medicaments for treatment of associated disorders. The compounds are of formula I:
in which R1 is a halo-alkyl group and A is an optionally substituted aromatic heterocyclic or carbocyclic ring system,
or a pharmaceutically acceptable salt or solvate thereof.
本发明涉及具有
钠通道阻滞特性的三嗪化合物,并且涉及使用该化合物制备治疗相关疾病的药物。该化合物的
化学式为I:其中,R1是卤代烷基,A是可选取的取代芳香异环或碳环系统,或其药学上可接受的盐或溶剂。